Harrow Stock

Harrow Net Margin

The Net Profit Margin of Harrow (HROW) as of Jul 25, 2026 is -1.89 %. In the previous year, Net Profit Margin was -8.76 % — a change of -78.45% (higher).

Net Margin

-1.89 %

YoY

-78.45%

Last updated:

Net Profit Margin of Harrow is 2026 -1.89 % . Net Profit Margin of Harrow was 2025 -8.76 % . It decreases by -78.45% higher compared to the previous year.

For Harrow, the net margin of -1.9% is up versus -24.8% a few years ago.

Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

Net Profit Margin of Harrow is -1.89 % in 2026.

Access this data via the Eulerpool API

Margins — Harrow

All Key Metrics — Harrow